Please login to the form below

Not currently logged in
Email:
Password:

New accounts: December

The following table lists new pharmaceutical account wins notified to us by the winning agencies for the period September to November 2005 inclusive

The following table lists new pharmaceutical account wins notified to us by the winning agencies for the period September to November 2005 inclusive. Please note that inclusion in this table does not necessarily indicate exclusivity and other agencies may also be involved with some of the products listed in other ways, or in domestic, overseas or international markets. To submit an entry for New Accounts, email nhobson@pmlive.com

GlaxoSmithKline

Cervarix

Cervical cancer (consumer healthcare)

Clew Communications

GlaxoSmithKline

Cervarix

Cervical cancer

Virgo HEALTH PR

Gr˙nenthal

New product launch

N/A

Jango Communications

Haemophilia Society

N/A

Corporate

Red Door Communications

Isolagen UK

Corporate and business programme

N/A

Ruder Finn UK

LiDCO

LiDCO

Intensive care medicine

Reynolds-MacKenzie

MSD

N/A

Internet

LeapFrog Medical

Novartis

Exjade

Sickle cell disease

Avenue

Novartis

Glivec

Oncology - GIST

Avenue

Novartis

N/A

Ophthalmics

LeapFrog Medical

Novartis

Transplantation portfolio

Transplantation

LeapFrog Medical

Oxford Immunotec

N/A

N/A

Virgo HEALTH PR

Pfizer

Lyrica

Epilepsy

TVF Communications

Pfizer

Injectable contraceptive

Contraception

Ruder Finn

Pharmion

N/A

N/A

Virgo HEALTH PR

Procter & Gamble

Asacol

Inflammatory bowel disease

Resolute Communications

Roche

Avastin

Oncology

Ketchum

Roche

MabThera

Rheumatoid arthritis

Red Door Communications

Solvay

Omacor

Cardiology

LeapFrog Medical

Viatris Consumer Brands

Osteo-life

Calcium supplement

hsdcommunications

2nd September 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cello Health Insight

Cello Health Insight is the global market research arm of Cello Health. With 35 years’ sector experience, we specialise in...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics